Tenax Therapeutics Inc (NASDAQ:TENX)

3.20
Delayed Data
As of Feb 26
 -0.07 / -2.14%
Today’s Change
3.01
Today|||52-Week Range
8.35
-16.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues322.3K100.5K92.7K25.7K
 
 
 
 
 
Cost of Goods Sold219.2K51.3K43.1K129.8K
 
 
 
 
 
Depreciation And Amortization311.0K206.7K154.0K156.2K
 
 
 
 
 
 
Operating ExpensesGross Income-207.9K-157.4K-104.4K-260.3K
 
 
 
 
 
General Expenses--8.3M6.0M16.6M
 
 
 
 
Research And Development2.7M2.5M2.4M3.0M
 
 
 
 
 
Total Operating Expenses10.6M8.6M6.2M16.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.3M-8.5M-6.1M-16.9M
 
 
 
 
 
Extraordinary Charge-302.0K-29.5K-248.0K-721.8K
 
 
 
 
 
Interest Expense On Debt171.6K7.4M4.2M2.2M
 
 
 
 
 
Other Expenses--234.4K1.2M266.4K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.4M-15.7M-9.4M-19.5M
 
 
 
 
 
Preferred Dividend0.000.00-958.1K-5.8M
 
 
 
Net Income-10.4M-15.7M-9.4M-19.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.2M1.3M1.7M9.4M
 
 
 
 
 
Shares To Calculate EPS Diluted1.2M1.4M1.8M9.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$9.00-$14.00-$133.60-$2.71
 
 
 
 
 
EPS Diluted-$9.00-$14.00-$6.68-$2.71
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account